Thursday 22 September 2011

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.


1. Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.
Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, Whirl-Carrillo M, Wheeler MT, Dudley JT, Byrnes JK, Cornejo OE, Knowles JW, Woon M, Sangkuhl K, Gong L, Thorn CF, Hebert JM, Capriotti E, David SP, Pavlovic A, West A, Thakuria JV, Ball MP, Zaranek AW, Rehm HL, Church GM, West JS, Bustamante CD, Snyder M, Altman RB, Klein TE, Butte AJ, Ashley EA.
PLoS Genet. 2011 Sep;7(9):e1002280. Epub 2011 Sep 15.
PMID: 21935354 [PubMed - in process]
2.ChIP-Seq: technical considerations for obtaining high-quality data.
Kidder BL, Hu G, Zhao K.
Nat Immunol. 2011 Sep 20;12(10):918-22. doi: 10.1038/ni.2117.
PMID: 21934668 [PubMed - in process]
3.Next-Generation Sequencing Reveals HIV-1-Mediated Suppression of T Cell Activation and RNA Processing and Regulation of Noncoding RNA Expression in a CD4+ T Cell Line.
Chang ST, Sova P, Peng X, Weiss J, Law GL, Palermo RE, Katze MG.
MBio. 2011 Sep 20;2(5). pii: e00134-11. doi: 10.1128/mBio.00134-11. Print 2011.
PMID: 21933919 [PubMed - in process]

No comments:

Post a Comment

Datanami, Woe be me